GlaxoSmithKline plc Cash Flow Quality Index
GlaxoSmithKline plc cash flow quality index. GlaxoSmithKline plc (GSKN) has a Cash Flow Quality Index of 1.10x as of September 2025. Operating cash flow of MX$2.22 Billion exceeds net income of MX$2.01 Billion, indicating high earnings quality where cash backs reported profits. Explore GSKN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of GlaxoSmithKline plc (2013–2024)
Cash flow quality index of GlaxoSmithKline plc from 2013 to 2024. Historical Cash Flow Quality Index for GlaxoSmithKline plc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. See GSKN equity to assets ratio to measure how much of total assets are equity-financed.
GlaxoSmithKline plc Cash Flow Quality Index by Year (2013–2024)
GlaxoSmithKline plc cash flow quality index by year from 2013 to 2024. Year-by-year earnings quality comparison for GlaxoSmithKline plc. For the full cash flow conversion analysis, see GlaxoSmithKline plc (GSKN) cash conversion ratio.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.55x | MX$6.55 Billion | MX$2.58 Billion | ▲ +129.0% |
| 2023 | 1.11x | MX$5.48 Billion | MX$4.93 Billion | ▲ +124.5% |
| 2022 | 0.49x | MX$7.40 Billion | MX$14.96 Billion | ▼ -72.7% |
| 2021 | 1.81x | MX$7.95 Billion | MX$4.38 Billion | ▲ +23.5% |
| 2020 | 1.47x | MX$8.44 Billion | MX$5.75 Billion | ▼ -15.0% |
| 2019 | 1.73x | MX$8.02 Billion | MX$4.64 Billion | ▼ -25.7% |
| 2018 | 2.32x | MX$8.42 Billion | MX$3.62 Billion | ▼ -48.5% |
| 2017 | 4.52x | MX$6.92 Billion | MX$1.53 Billion | ▼ -36.6% |
| 2016 | 7.12x | MX$6.50 Billion | MX$912.00 Million | ▲ +2235.4% |
| 2015 | 0.31x | MX$2.57 Billion | MX$8.42 Billion | ▼ -83.8% |
| 2014 | 1.88x | MX$5.18 Billion | MX$2.76 Billion | ▲ +41.4% |
| 2013 | 1.33x | MX$7.22 Billion | MX$5.44 Billion | — |